Acrivon Therapeutics, Inc. (ACRV) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The nearest decision zone is framed by support around 1.71 and resistance near 1.85. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 1.37, so a violation there would materially change the current setup narrative.

📊 Technical Summary

The latest close for Acrivon Therapeutics, Inc. (ACRV) came in at 1.85 (+2.21%). Price continues to hold above both the 50-day and 200-day moving averages, which keeps the broader trend structure constructive. 20-day momentum is notably strong at +26.71%; price remains inside its roughly 52-week range (1.05–3.01); and ATR14 volatility is elevated at roughly 6.88% of price. RSI(14) stands around 57.6, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The chart is currently flagging Double bottom. Near-term structure is defined by support at 1.71 and resistance at 1.85. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Net income: -18.23M · EPS (basic): -0.47. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more